All In MedTech

Device Trial Radar · NCT01820130

Trial of Autonomic neuroModulation for trEatment of Chronic Heart Failure

Last checked: Nov 19, 2026Latest source record: Feb 4, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Mar 2013

Primary completion

Sep 2016

Study completion Sep 2016

Sponsor

Lead sponsor
Abbott Medical DevicesPublic (ABT)
Sponsor type
Industry
First posted
Mar 28, 2013

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this clinical investigation is to evaluate the safety and efficacy of Spinal Cord Stimulation (SCS) in advanced heart failure (HF) patients with Implantable Cardioverter Defibrillator (ICD) but not indicated for Cardiac Resynchronization Therapy (CRT).

Conditions

  • Heart Failure

Interventions

  • St Jude Medical EON mini rechargeable systemDevice

    implantation of Eon Mini Neurostimulation System (IPG Model 3788)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy Marker of Cardiac remodeling via Left Ventricular End Diastolic Volume (LVEDV) of Patient with advanced HFTime frame: baseline and 6 Months
  2. Efficacy Marker of patient symptom via NYHA class for patient with advanced HFTime frame: Baseline and 6 months
  3. Efficacy Marker of patient symptom via 6 Minutes Hall Walk distance for patient with advanced HFTime frame: baseline to 6 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • CHU

    Pessac, France

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.